Bio Essence Corp (BIOE) stock
Close on Oct 19, 2026Market cap $21.38MP/E 10.5Yield –
Bio Essence Corp grew revenue 416.6% to $2.91M over the twelve months to Jun 30, 2026. At the latest close the market valued the company at $21.38M, 10.5 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $21.38M
- P/E ratio
- 10.5
- Price to sales
- 7.34
- Price to book
- 9.13
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $2.91M
- Net income
- $1.52M
- EPS, diluted
- $0.04
- Book value per share
- $0.05
- Diluted shares
- 51M
Trading
- Previous close
- $0.39
- Open
- $0.42
- Day's range
- $0.42 – $0.42
- Volume
- 4,999
- Average volume (20 days)
- 28,432
Market cap history
Month-end market cap since 2024, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | BIOE | S&P 500 | Difference | BIOE per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +130.8% | +0.6% | +130.2 pts | ||
| 3 months | +55.6% | +3.4% | +52.2 pts | ||
| Year to date | +600.2% | +13.3% | +586.9 pts | ||
| 1 year | +511.5% | +16.6% | +494.9 pts |
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Bio Essence filed with the SEC as exhibits to Form 8-K or 6-K
About Bio Essence
Pharmaceutical Preparations
Bio Essence Corp. is an herbal health, diet, and nutrition company that provides herbal health, diet, and vitamin nutritional supplements. The company operates by selling health supplement products and offering original equipment manufacturing (OEM) and private-label services to corporate clients. Its offerings historically encompassed traditional Chinese medicines such as single herbs, granules, pills, and tablets, alongside dietary formulas and medical foods. Following corporate restructuring, the company manages its commercial activities directly and outsources manufacturing and OEM production. Its customer base includes corporate clients contracting for outsourced product development and manufacturing services.
Company profile, executives and historyBio Essence stock: common questions
What is Bio Essence's stock price?
BIOE closed at $0.42 on Oct 19, 2026, up 7.72% on the day.
What is Bio Essence's market cap?
Bio Essence was worth $21.38M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is BIOE's P/E ratio?
BIOE trades at 10.5 times earnings, based on diluted earnings per share of $0.04 over the twelve months to Jun 30, 2026.
How much revenue does Bio Essence make?
Bio Essence reported revenue of $2.91M for the twelve months to Jun 30, 2026, up 416.6% from a year earlier.
Does Bio Essence pay a dividend?
No. Bio Essence has not paid a cash dividend over the last twelve months.
How has BIOE stock performed over the past year?
Including dividends, BIOE returned +511.5% over the past year, against +16.6% for the S&P 500.
Who are Bio Essence's competitors?
Companies most similar to Bio Essence by business, industry and size include TXMD, PMHS, HYEX, ELAB, PRPH.
See a number that looks wrong?